^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

YTS105

i
Other names: YTS105, S105, MSLN STAR-T Cells
Associations
Company:
BriSTAR Immunotech, Peking University
Drug class:
Mesothelin-targeted CAR-T immunotherapy
Associations
over2years
New P1 trial
|
EGFR (Epidermal growth factor receptor) • ALK (Anaplastic lymphoma kinase) • MET (MET proto-oncogene, receptor tyrosine kinase) • ROS1 (Proto-Oncogene Tyrosine-Protein Kinase ROS) • MSLN (Mesothelin)
|
ALK positive • EGFR positive • EGFR negative • MSLN positive
|
YTS105